Document is current

Article History

Received: 13 March 2026

Accepted: 8 July 2026

First Online: 29 July 2026

Declarations

Ethical approval: The EMBRACE trial received ethical approval from the Monash University Human Research Ethics Committee (ID 35,525). The research was conducted in accordance with the World Medical Association Declaration of Helsinki.

Consent to participate: Written informed consent was obtained from all knowledge brokers and RACFs (consent obtained from RACF manager or an authorised representative of the aged care provider organisation).

Consent to publish: Not applicable.

Competing interests: A.J.C. has received grant funding or consulting funds from the National Health and Medical Research Council, Medical Research Future Fund, Dementia Australia and Pharmaceutical Society of Australia. All grants and consulting funds were paid to the employing institution. A.J.C also declares she is a national board director for the Pharmaceutical Society of Australia, the peak body representing Australian pharmacists. J.W. has received grant funding from Dementia Australia and The University of Sydney for projects unrelated to this work. All grants were paid to the employing institution. C.D.P. has received grant funding or consulting funds from the National Health and Medical Research Council, Medicines Australia, Dementia Training Australia, Australian Dementia Network, Hunter New England and Central Coast Primary Health Network. A.K. has received grant funding or consulting funds from the National Health and Medical research Council, Medical Research Future Fund and several small research charities unrelated to this work. All grants were paid to the employing institution. J.S.B. has received grant funding or consulting funds from the National Health and Medical Research Council, Medical Research Future Fund, Victorian Government Department of Health and Human Services, Dementia Australia Research Foundation, Yulgilbar Foundation, Aged Care Quality and Safety Commission, Dementia Centre for Research Collaboration, Pharmaceutical Society of Australia, Society of Hospital Pharmacists of Australia, GlaxoSmithKline Supported Studies Programme, Amgen, and several aged care provider organisations unrelated to this work. All grants and consulting funds were paid to the employing institution. The other authors declare that they have no competing interests relevant to this manuscript.